title: Founder BRCA1/2 mutations among male patients with breast cancer in Israel.
authors.forename: J P
authors.initials: JP
authors.lastname: Struewing
authors.forename: Z M
authors.initials: ZM
authors.lastname: Coriaty
authors.forename: E
authors.initials: E
authors.lastname: Ron
authors.forename: A
authors.initials: A
authors.lastname: Livoff
authors.forename: M
authors.initials: M
authors.lastname: Konichezky
authors.forename: P
authors.initials: P
authors.lastname: Cohen
authors.forename: M B
authors.initials: MB
authors.lastname: Resnick
authors.forename: B
authors.initials: B
authors.lastname: Lifzchiz-Mercerl
authors.forename: S
authors.initials: S
authors.lastname: Lew
authors.forename: J
authors.initials: J
authors.lastname: Iscovich
mesh_terms: D018912:Arabs / Q000235:genetics; D024682:BRCA2 Protein; D018567:Breast Neoplasms, Male / Q000235:genetics*; D004252:DNA Mutational Analysis; D018703:Founder Effect; D019398:Genes, BRCA1 / Q000235:genetics*; D005820:Genetic Testing; D018095:Germ-Line Mutation / Q000235:genetics*; D006801:Humans; D007557:Israel; D007585:Jews / Q000235:genetics; D008297:Male; D009363:Neoplasm Proteins / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors